Role of Neuroinflammation in Neurodegenerative Diseases: Therapeutic Perspectives
Year: 2026
Type: article
Abstract: Neuroinflammation has emerged as a major contributing factor in the progression of neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, and Amyotrophic Lateral Sclerosis. This review highlights the role of inflammatory pathways and immune-mediated mechanisms involved in neuronal degeneration. Activation of microglia and astrocytes leads to the release of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, which contribute to neuronal damage and synaptic dysfunction. Key molecular pathways including NF-κB signaling, NLRP3 inflammasome activation, oxidative stress, mitochondrial dysfunction, and abnormal protein aggregation are critically involved in disease pathogenesis. Protein aggregates such as amyloid-β and α-synuclein further stimulate chronic inflammatory responses, accelerating neurodegeneration. Current therapeutic approaches mainly provide symptomatic relief and include cholinesterase inhibitors, dopamine agonists, immunomodulators, and antioxidant therapies. However, these treatments are limited by poor blood–brain barrier penetration and inability to halt disease progression. Emerging therapeutic strategies targeting neuroinflammation, including cytokine inhibitors, NLRP3 inflammasome blockers, monoclonal antibodies, stem cell therapy, gene therapy, and nanotechnology-based drug delivery systems, show promising potential as disease-modifying interventions. Understanding the molecular basis of neuroinflammation may facilitate the development of personalized and effective therapeutic approaches for neurodegenerative disorders in the future.
Author: Darshan R.*, Kusu Susan Cyriac
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7162106486
